Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Alexandre Gaudet et al.|Science Immunology|2021Cited by 638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Proceedings of the National Academy of Sciences|2022Cited by 198
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patientsDavid Lebeaux, D. Sène, C. Françès et al.|Lara D. Veeken|2011Cited by 170
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Research Square|2022Cited by 24
Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patientsE. Zuelgaray, D. Sène, Sylvie Chevret et al.|Journal of the American Academy of Dermatology|2020Cited by 17